Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: toccodolce who wrote (7588)	8/6/2001 10:59:09 AM
From: Montana Wildhack	Respond to of 14101

Tom, I'm suspicious of these average numbers. Regardless, its clear Dimethaid is not falling into this range for the Pennsaid product. It'll get more interesting when 'we' have 2 products in front of the FDA for approval. I've been looking through the AS Bryden website and wrote to ask for more information. I did find that they are distributors for these companies. Abbott Laboratories Approved Prescription Services The Boots Company PLC Glaxo Wellcome Laboratories Janssen Cilag Caribbean Kodak Caceo Limited Medeva Limited Optrex Limited (Division of Boots PLC) Stiefel Laboratories Tillotts Limited Warner Lambert & Company They appear to be located on 6 of the islands and I am trying to determine how many of the islands they service. I've always had a warm spot for the carribean and in fact manage an integrated computer system on most of those same islands. I also asked when they expect to be able to make it available. It's not large; but, it is real and is the second market for Pennsaid so far. FDA will come when it comes and it will. If we were dealing with unsolvable remaining issues, they would have closed the file by now. Wolf